Literature DB >> 30739908

Genetic diversity and pathogenic variants as possible predictors of severity in a French sample of nonsyndromic heritable thoracic aortic aneurysms and dissections (nshTAAD).

Pauline Arnaud1,2,3, Nadine Hanna1,2,3, Louise Benarroch2, Mélodie Aubart2, Laurence Bal4, Patrice Bouvagnet5, Tiffany Busa6, Yves Dulac7, Sophie Dupuis-Girod8, Thomas Edouard9, Laurence Faivre10, Laurent Gouya3, Didier Lacombe11,12, Maud Langeois3, Bruno Leheup13, Olivier Milleron3, Sophie Naudion11, Sylvie Odent14, Maria Tchitchinadze3, Jacques Ropers15, Guillaume Jondeau2,3, Catherine Boileau16,17,18.   

Abstract

PURPOSE: Heritable thoracic aortic aneurysms and dissections (hTAAD) are life-threatening complications of well-known syndromic diseases or underdiagnosed nonsyndromic heritable forms (nshTAAD). Both have an autosomal dominant transmission and are genetically heterogeneous. Our objective was to describe the relevance of molecular diagnosis in these patients and the contribution of each gene in nshTAAD.
METHODS: Two hundred twenty-six consecutive nshTAAD probands, either young (<45 years) sporadic or familial cases were included. A next-generation sequencing capture panel comprising 23 known disease-causing genes was performed.
RESULTS: Class 4 or 5 variants were identified in 18% of the nshTAAD probands, while class 3 variants were found in 10% of them. The yield in familial cases was greater than in sporadic cases. SMAD3 and FBN1 genes were the major disease-causing genes. Unexpectedly, no premature termination codon variant was identified in the FBN1 gene. Furthermore, we report for the first time that aortic dissection or surgery occurred significantly more often and earlier in probands with a class 4 or 5 pathogenic variant.
CONCLUSION: This study indicates that genetic screening using NGS is efficient in young and familial nshTAAD. The presence of a pathogenic variant has a possible predictive value, which needs to be further investigated because it may influence care.

Entities:  

Keywords:  FBN1 gene; NGS; SMAD3 gene; class 4 and 5 variants; thoracic aortic aneurysms and dissections

Mesh:

Substances:

Year:  2019        PMID: 30739908     DOI: 10.1038/s41436-019-0444-y

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  15 in total

1.  Analysis of the contribution of 129 candidate genes to thoracic aortic aneurysm or dissection of a mixed cohort of sporadic and familial cases in South China.

Authors:  Ying Li; Miaoxian Fang; Jue Yang; Changjiang Yu; Juntao Kuang; Tucheng Sun; Ruixin Fan
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

Review 2.  Role of Clinical Genetic Testing in the Management of Aortopathies.

Authors:  Stephanie L Harris; Mark E Lindsay
Journal:  Curr Cardiol Rep       Date:  2021-01-21       Impact factor: 2.931

3.  [Gene mutation analysis of 19 Uighur families with aortic disease in Kashgar, China].

Authors:  Changjiang Yu; Ying Li; Abuduresuli Adilijang; Jizhong Yan; Arkin Guzalnur; Abudula Abudushalamu; Yimamu Aimirela; Ruixin Fan
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2020-11-30

4.  Identification of COL3A1 variants associated with sporadic thoracic aortic dissection: a case-control study.

Authors:  Yanghui Chen; Yang Sun; Zongzhe Li; Chenze Li; Lei Xiao; Jiaqi Dai; Shiyang Li; Hao Liu; Dong Hu; Dongyang Wu; Senlin Hu; Bo Yu; Peng Chen; Ping Xu; Wei Kong; Dao Wen Wang
Journal:  Front Med       Date:  2021-05-28       Impact factor: 4.592

5.  Preventing Acute Aortic Dissections: The Power of Familial Screening and Risk Assessment.

Authors:  Alana C Cecchi; Maura L Boerio; Isabella Marin; Amélie Pinard; Dianna M Milewicz
Journal:  J Am Heart Assoc       Date:  2022-04-06       Impact factor: 6.106

Review 6.  The Genetics of Thoracic Aortic Aneurysms and Dissection: A Clinical Perspective.

Authors:  Nicolai P Ostberg; Mohammad A Zafar; Bulat A Ziganshin; John A Elefteriades
Journal:  Biomolecules       Date:  2020-01-24

7.  A +3 variant at a donor splice site leads to a skipping of the MYH11 exon 32, a recurrent RNA defect causing Heritable Thoracic Aortic Aneurysm and Dissection and/or Patent Ductus Arteriosus.

Authors:  Bertrand Chesneau; Aurélie Plancke; Guillaume Rolland; Bertrand Marcheix; Yves Dulac; Thomas Edouard; Julie Plaisancié; Marion Aubert-Mucca; Sophie Julia; Maud Langeois; Thierry Lavabre-Bertrand; Philippe Khau Van Kien
Journal:  Mol Genet Genomic Med       Date:  2021-10-21       Impact factor: 2.183

Review 8.  Inherited Thoracic Aortic Disease: New Insights and Translational Targets.

Authors:  Alexander J Fletcher; Maaz B J Syed; Timothy J Aitman; David E Newby; Niki L Walker
Journal:  Circulation       Date:  2020-05-11       Impact factor: 29.690

9.  Genetic Variation in LRP1 Associates with Stanford Type B Aortic Dissection Risk and Clinical Outcome.

Authors:  Philipp Erhart; Daniel Körfer; Caspar Grond-Ginsbach; Jia-Lu Qiao; Moritz S Bischoff; Maja Hempel; Christian P Schaaf; Armin Grau; Dittmar Böckler
Journal:  J Cardiovasc Dev Dis       Date:  2022-01-05

10.  Pregnancy outcome in thoracic aortic disease data from the Registry Of Pregnancy And Cardiac disease.

Authors:  Laurence Campens; Lucia Baris; Nandita S Scott; Craig S Broberg; Antione Bondue; Guillaume Jondeau; Jasmine Grewal; Mark R Johnson; Roger Hall; Julie De Backer; Jolien W Roos-Hesselink
Journal:  Heart       Date:  2021-01-19       Impact factor: 5.994

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.